Interactive Impacts from Hepatitis C Virus Infection and Mixed Cryoglobulinemia on Complement Levels

Area of Science:

• Immunology
• Virology
• Hepatology

Background:

• Hepatitis C virus (HCV) infection is common and can lead to chronic liver disease.
• Mixed cryoglobulinemia is a potential complication of HCV infection.
• The interplay between HCV, mixed cryoglobulinemia, and complement levels is not fully understood.

Purpose of the Study:

• To investigate how hepatitis C virus (HCV) infection and mixed cryoglobulinemia interact to influence complement levels.
• To elucidate the specific effects on complement components C3 and C4.

Main Methods:

• A prospective cohort study of 678 patients with chronic HCV infection.
• Collected data on complement levels (C3, C4) and mixed cryoglobulinemia status at baseline and 24 weeks post-therapy.
• Analyzed factors associated with complement levels before and after anti-HCV therapy, including sustained virological response (SVR).

Main Results:

• Lower C3 and C4 levels were observed in patients with mixed cryoglobulinemia at baseline.
• Factors influencing C3 levels included IFNL3 genotype, triglycerides, cirrhosis, and eGFR; C4 levels were associated with cirrhosis, sex, and hs-CRP.
• SVR patients without mixed cryoglobulinemia showed increased C3, while those with pre-therapy mixed cryoglobulinemia had increased C4. Lower C3 was noted in SVR patients with post-therapy mixed cryoglobulinemia.

Conclusions:

• HCV impacts C3 and C4 levels through various factors including genetics, metabolic status, liver disease severity, and renal function.
• Mixed cryoglobulinemia and HCV infection exhibit complex interactions, antagonistically and synergistically affecting C3 and C4 levels, respectively.
• Complement component levels are altered by the presence of mixed cryoglobulinemia and response to HCV therapy.